Updated

Medical researchers and doctors are investigating the possibility that GLP-1 receptor agonist drugs—widely used for weight loss and diabetes management—may offer relief from chronic back and knee pain, though the mechanism remains unclear. However, physicians are urging caution, noting that the rapid weight loss associated with these medications can lead to bone-quality deterioration, particularly in older adults, potentially offsetting pain relief benefits and creating new health risks.